跳至主要内容
临床试验/JPRN-jRCTs031180209
JPRN-jRCTs031180209已完成2 期

Sequential therapy with vonoprazan, amoxicillin 7 days and vonoprazan, metronidazole, and sitafloxacin 7 days versus triple therapy with vonoprazan, amoxicillin, and metronidazole 7 days for early age Helicobacter pylori infection: a multicenter, open-label, randomized trial

Sue Soichiro0 个研究点目标入组 12 人开始时间: 2019年3月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

This study showed potential of 14-day sequential therapy containing vonoprazan and amoxicillin for 7 days followed by vonoprazan, metronidazole and sitafloxacin for 7 days and 7-day triple therapy with vonoprazan, amoxicillin and metronidazole. There was no problem in safety.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 40age old(—)
性别
All

入选标准

  • (1) A patient with Helicobacter pylori infection.
  • (2) A patient who can perform stool antigen test of Helicobacter pylori after 8 weeks from treatment completion.
  • (3)A patient who give a written informed consent.

排除标准

  • (1) A patient with history of Helicobacter pylori eradication.
  • (2) Pregnancy.
  • (3) Lactation.
  • (4) Patients allergic to penicillin.
  • (5) Past history of allergy for the drugs used in this study.
  • (6) A patient with brain and spinal cord disease.
  • (7) A patient with infectious mononucleosis.
  • (8) Severe liver dysfunction, serere renal dysfunction, severe heart dysfunction.
  • (9) Patient who is disualified for the study by physicians.

研究者

发起方
Sue Soichiro

相似试验